The global home infusion therapy market size was estimated to be USD 23.35 billion in 2023 and is expected to reach at USD 51.3 billion by 2033 with a CAGR of 7.42% during the forecast period 2023-2033. Increasing number of baby boomers are experiencing diminished movement due to conditions including osteoarthritis, paralysis, & diabetes, rising preference for in-home care, growing utilization of next generation infusion pumps in home care settings, surge in advancements in administering infusion therapy, increasing urge to shorten inpatient stays, quick adoption of smart infusion pumps include exciting features including EHR connection, drug libraries, & medication safety software, and rising partnership within market players for the development of advanced technologies are some of the key factors boosting the market growth.
Rising partnership within market players for the development of advanced technologies is predicted to boost the market growth during the forecast period. For instance, in December 2022, Together, Option Care Health Inc. and WellSky will advance technologies in the areas of home and ambulatory infusion. This partnership aims to provide new features to WellSky's CareTend, a platform for infusion and specialty pharmaceutical services.
By Product, Infusion pumps was the highest revenue-grossing segment in the global home infusion therapy market in 2022 owing to surge in demand for smart pumps, improving the usage & effectiveness of the delivery of nutrients, drugs, & other necessary fluids in the necessary amounts, increasing demand for home health care services, and growing introduction of advanced technology. For instance, in January 2021, A graduate from OSU has introduced a novel technology named IV Ensure, with the goal of transforming at-home infusion therapy. This innovative device utilizes remote monitoring to enable patients to track their well-being, enhancing adherence and ultimately leading to improved health results. Additionally, Needleless connectors is predicted to grow at fastest CAGR during the forecast period owing to several advantages, including a lower risk of bacterial contamination and increased safety from needlestick incidents and growing demand for needleless connectors.
By Application, Anti-infective therapy was the highest revenue-grossing segment in the global home infusion therapy market in 2022 owing to the growing awareness initiatives by various government organizations, rising prevalence of infectious diseases, increasing research & development activities, and surge in investment by market players. Additionally, Chemotherapy is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for pressure pumps, increasing technological advancements, rising prevalence of chronic diseases, and surge in regulatory approvals. For instance, in March 2022, China's National Medical Products Administration (NMPA) has granted marketing approval to Shanghai MicroPort Lifesciences Co., Ltd. for their newly developed AutoEx® Chemotherapy Infusion Pump (AutoEx®), which they created independently.
By End-user, Patients was the highest revenue-grossing segment in the global home infusion therapy market in 2022 owing to the increasing focus on infusion pumps designed for home care are portable, light, & easy to use so that patients can use them independently if required, rising preference of home-infusion therapy, growing prevalence of hospital acquired infections, and surge in development of advanced systems. For instance, in February 2020, Avoset has created AvosetGO, a homecare solution consisting of an infusion pump apparatus that features built-in touch screens. These touch screens can be linked and monitored through smart devices. Additionally, Hospitals is predicted to grow at fastest CAGR during the forecast period owing to the surge in adoption of advanced & smart infusion pumps, growing focus on patients’ safety, and increasing introduction of cutting-edge technologies.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of chronic diseases, growing technological advancements, rising product launches, increasing shift from hospital facilities to home care settings, and surge in partnership within market players. For instance, in May 2021, Ivenix, Inc. and Smiths Medical have collaborated through a partnership agreement to offer a comprehensive selection of infusion management solutions in the United States market. This collaboration aims to advance infusion management for the enhancement of patient safety. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing preference for in-home care, surge in advancements in healthcare sector, growing adoption of smart infusion pumps, and rising collaborations within market players. For instance, in March 2021, Terumo and Glooko, a company specializing in remote patient monitoring software and mobile apps, have unveiled a technological collaboration to introduce innovative diabetes data solutions on a global scale. This partnership will enable the incorporation of data from Terumo's diabetes care devices into Glooko's diasend platform for diabetes data management.
Rising partnership within market players for the development of advanced technologies is predicted to boost the market growth during the forecast period. For instance, in December 2022, Together, Option Care Health Inc. and WellSky will advance technologies in the areas of home and ambulatory infusion. This partnership aims to provide new features to WellSky's CareTend, a platform for infusion and specialty pharmaceutical services.
By Product, Infusion pumps was the highest revenue-grossing segment in the global home infusion therapy market in 2022 owing to surge in demand for smart pumps, improving the usage & effectiveness of the delivery of nutrients, drugs, & other necessary fluids in the necessary amounts, increasing demand for home health care services, and growing introduction of advanced technology. For instance, in January 2021, A graduate from OSU has introduced a novel technology named IV Ensure, with the goal of transforming at-home infusion therapy. This innovative device utilizes remote monitoring to enable patients to track their well-being, enhancing adherence and ultimately leading to improved health results. Additionally, Needleless connectors is predicted to grow at fastest CAGR during the forecast period owing to several advantages, including a lower risk of bacterial contamination and increased safety from needlestick incidents and growing demand for needleless connectors.
By Application, Anti-infective therapy was the highest revenue-grossing segment in the global home infusion therapy market in 2022 owing to the growing awareness initiatives by various government organizations, rising prevalence of infectious diseases, increasing research & development activities, and surge in investment by market players. Additionally, Chemotherapy is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for pressure pumps, increasing technological advancements, rising prevalence of chronic diseases, and surge in regulatory approvals. For instance, in March 2022, China's National Medical Products Administration (NMPA) has granted marketing approval to Shanghai MicroPort Lifesciences Co., Ltd. for their newly developed AutoEx® Chemotherapy Infusion Pump (AutoEx®), which they created independently.
By End-user, Patients was the highest revenue-grossing segment in the global home infusion therapy market in 2022 owing to the increasing focus on infusion pumps designed for home care are portable, light, & easy to use so that patients can use them independently if required, rising preference of home-infusion therapy, growing prevalence of hospital acquired infections, and surge in development of advanced systems. For instance, in February 2020, Avoset has created AvosetGO, a homecare solution consisting of an infusion pump apparatus that features built-in touch screens. These touch screens can be linked and monitored through smart devices. Additionally, Hospitals is predicted to grow at fastest CAGR during the forecast period owing to the surge in adoption of advanced & smart infusion pumps, growing focus on patients’ safety, and increasing introduction of cutting-edge technologies.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of chronic diseases, growing technological advancements, rising product launches, increasing shift from hospital facilities to home care settings, and surge in partnership within market players. For instance, in May 2021, Ivenix, Inc. and Smiths Medical have collaborated through a partnership agreement to offer a comprehensive selection of infusion management solutions in the United States market. This collaboration aims to advance infusion management for the enhancement of patient safety. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing preference for in-home care, surge in advancements in healthcare sector, growing adoption of smart infusion pumps, and rising collaborations within market players. For instance, in March 2021, Terumo and Glooko, a company specializing in remote patient monitoring software and mobile apps, have unveiled a technological collaboration to introduce innovative diabetes data solutions on a global scale. This partnership will enable the incorporation of data from Terumo's diabetes care devices into Glooko's diasend platform for diabetes data management.
Segmentation: Home Infusion Therapy Market Report 2022 - 2033
Home Infusion Therapy Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
- Infusion Pumps
- IV Cannulas
- Needleless Connectors
- Intravenous Sets
Home Infusion Therapy Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Hydration Therapy
- Chemotherapy
- Enteral Nutrition
- Anti-infective Therapy
- IVIg/Specialty Pharmaceuticals
- Total Parenteral Nutrition
- Others
Home Infusion Therapy Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Nurse
- Hospitals
- Patients
- Others
Home Infusion Therapy Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Home Infusion Therapy Market: Product Estimates & Trend Analysis
8. Home Infusion Therapy Market: Application Estimates & Trend Analysis
9. Home Infusion Therapy Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Home Infusion Therapy Market
12. Europe Global Home Infusion Therapy Market
13. Asia Pacific Global Home Infusion Therapy Market
14. Latin America Global Home Infusion Therapy Market
15. MEA Global Home Infusion Therapy Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- CareCentrix Inc.
- Fresenius Kabi
- B. Braun Melsungen AG
- ICU Medical Inc.
- Nipro Corporation
- Becton Dickinson and Companies
- McLaren Health Care
- Catholic Health Initiatives
- Smiths Medical
- Community Surgical Supply
- Eli Lilly and Company
- Sutter Health
- Terumo Corporation
- Option Care Health Inc.
- Baxter International
- McKesson Medical-Surgical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 23.35 Billion |
| Forecasted Market Value ( USD | $ 51.3 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
